β＿2受体激动剂特布嗪治疗高原慢阻肺和肺心病疗效观察  

OBSERVATION OF ALTITUDE COPD ANE COR PULMONALE TREATED BY TEBUQIN ,β_2 -ACCEPTOR EXCITANT

作　　者：张海明[1] 赵华[1] 顾玉海[1] 杨小梅[1] 杜玉梅[1] 刘金荣[1] 

机构地区：[1]青海省人民医院呼吸内科

出　　处：《高原医学杂志》1995年第3期24-26,共3页Journal of High Altitude Medicine

摘　　要：本文报告５４例海拔２３００～３７２０ｍ处慢性阻塞性肺疾病、肺心病患者使用新型β＿２受体激动剂特布唉的肺功能（ＶＣ．ＦＶＣ．ＦＥＶ＿（１．０）ＰＥＦＦＥＦ＿（５０））、动脉血气（ＰａＯ＿２ＰａＣＯ＿２ＳａｔＯ＿２）及临床疗效对比研究结果表明，特布嗪对慢阻肺、肺心病患者有较强的支气管扩张作用，降低气道高反应性，改善通气量，提高血氧分压，作用时间长，副作用较少，是临床治疗支气管痉挛迅速而有效的较好药物。he paper reporied comparison of clinical effects and pulrnonary function(VC, FVC, FEV_(1.0),PEF, FEF_(50)) and aterial blood gas analysis(PaO_2,PaCO_2.SatO_2)of 54 Chronic Obstructive PulmonaryDisease (COPD ) and Cor pulmonale patients treated by Tebuqin(Tubobulerol HydrorhOriAe),a kindof new β _2-acceptor excitant at 2 300～3700 meters above sew level.The results showed that Tebuqinhad strong effect of bronchiectasis and decreased high reaction of the airway and improved vantilationreverse and enhanced blfor PO_2. It had features of long time action and a few side effects.It is a betterdrug to treat bronchospasm quickly and effectively.

关 键 词：慢阻肺 肺心病 Β2受体激动剂 特布嗪 

分 类 号：R563.05[医药卫生—呼吸系统] R541.505[医药卫生—内科学]